Globus Medical (GMED) Capital Expenditures (2011 - 2026)

Globus Medical (GMED) has 16 years of Capital Expenditures data on file, last reported at $39.6 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures rose 9.73% year-over-year to $39.6 million; the trailing twelve-month figure through Mar 2026 stood at $168.2 million (up 15.12% YoY), and the FY2025 full-year result was $164.7 million, up 42.67% from the prior year.
• Capital Expenditures for Q1 2026 stood at $39.6 million, down from $151.2 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $151.2 million in Q4 2025 and bottomed at -$69.2 million in Q3 2025.
• The 5-year median for Capital Expenditures is $22.9 million (2023), against an average of $23.8 million.
• Peak annual rise in Capital Expenditures reached 110291.3% in 2022, while the deepest fall reached 4655.09% in 2022.
• A 5-year view of Capital Expenditures shows it stood at -$48.3 million in 2022, then jumped by 147.39% to $22.9 million in 2023, then declined by 25.22% to $17.1 million in 2024, then jumped by 783.79% to $151.2 million in 2025, then slumped by 73.8% to $39.6 million in 2026.
• The last three Capital Expenditures figures came in at $39.6 million (Q1 2026), $151.2 million (Q4 2025), and -$69.2 million (Q3 2025), per Business Quant data.

Peer Comparison